Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Express Scripts
Queensland Health
QuintilesIMS
Boehringer Ingelheim
Chubb
Merck
McKesson

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022458

« Back to Dashboard

NDA 022458 describes ELELYSO, which is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the ELELYSO profile page.

The generic ingredient in ELELYSO is taliglucerase alfa. One supplier is listed for this compound. Additional details are available on the taliglucerase alfa profile page.
Summary for 022458
Tradename:ELELYSO
Applicant:Pfizer
Ingredient:taliglucerase alfa
Patents:3
Pharmacology for NDA: 022458
Ingredient-typeGlucosylceramidase
Suppliers and Packaging for NDA: 022458
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELELYSO taliglucerase alfa POWDER;IV (INFUSION) 022458 NDA Pfizer Laboratories Div Pfizer Inc 0069-0106 N 0069-0106-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength200 UNITS/VIAL
Approval Date:May 1, 2012TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Feb 24, 2024Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ Sign UpPatent Expiration:Feb 24, 2024Product Flag?YSubstance Flag?YDelist Request?
Patent:➤ Sign UpPatent Expiration:Oct 18, 2025Product Flag?Substance Flag?Delist Request?
Patented Use:A METHOD OF CATALYZING THE HYDROLYSIS OF GLUCOCEREBROSIDE TO GLUCOSE AND CERAMIDE.

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Healthtrust
Chinese Patent Office
McKesson
Moodys
Teva
Federal Trade Commission
UBS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.